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Abstract
Capacity-building initiatives related to public health are defined as developing laboratory infrastructure,
strengthening host-country disease surveillance initiatives, transferring technical expertise and training personnel.
These initiatives represented a major piece of the Armed Forces Health Surveillance Center, Division of Global
Emerging Infections Surveillance and Response System (AFHSC-GEIS) contributions to worldwide emerging
infectious disease (EID) surveillance and response. Capacity-building initiatives were undertaken with over 80 local
and regional Ministries of Health, Agriculture and Defense, as well as other government entities and institutions
worldwide. The efforts supported at least 52 national influenza centers and other country-specific influenza,
regional and U.S.-based EID reference laboratories (44 civilian, eight military) in 46 countries worldwide. Equally
important, reference testing, laboratory infrastructure and equipment support was provided to over 500 field sites
in 74 countries worldwide from October 2008 to September 2009. These activities allowed countries to better meet
the milestones of implementation of the 2005 International Health Regulations and complemented many initiatives
undertaken by other U.S. government agencies, such as the U.S. Department of Health and Human Services, the
U.S. Agency for International Development and the U.S. Department of State.
Background
Capacity building, as it applies to health in this context,
can be accomplished through strengthening health
systems for delivery of medical care, pursuing medical
research initiatives to answer important local or regional
health questions, or supporting public health disease sur-
veillance to prioritize which diseases are affecting rele-
vant populations. Within this context, global public
health capacity building can be defined as developing
laboratory infrastructure, strengthening host-country dis-
ease surveillance initiatives, transferring technical exper-
tise and training personnel. Disease surveillance is often
the first step in improving public health because it
attempts to quantify needs and allocate scarce assets in
resource-limited settings, in addition to detecting poten-
tial outbreaks of disease.
Though not a new concept, capacity building has
enjoyed renewed prominence as the world endeavors to
meet requirements of International Health Regulations
2005 (IHR (2005)) [1]. Article 5 of the regulations requires
that all countries be able to detect, assess, notify and
report on public health issues of international significance
and control any potential public health event of interna-
tional concern by 2012. Some countries are capable now,
but most are not and will not be compliant by the deadline
unless a significant improvement in local capacity occurs.
In general, for capacity building to be successful in the
long term, efforts must not be undertaken quickly and
need to be implemented through a concerted unified
effort, achieving steady, sustainable and measurable pro-
gress over time, with the eventual goal being independence
from the provider of the capability.
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issued a report describing the global infectious disease
capacity-building efforts of U.S. government (USG)
entities [2]. At the time, three USG entities were iden-
tified as providing capacity building for emerging
infectious diseases (EID), including the U.S. Centers
for Disease Control and Prevention (CDC), the U.S.
Agency for International Development and the Depart-
ment of Defense’s Global Emerging Infections Surveil-
lance and Response System (DoD-GEIS). Their efforts
included laboratory-based disease surveillance, devel-
opment and testing of diagnostics, and training such as
Field Epidemiology TrainingP r o g r a m s ,t h ei n t e r n a -
tional version of the famed Epidemic Intelligence Ser-
vice [3]. Currently, many other USG agencies are
engaged in building disease surveillance capacity,
including the U.S. Department of State, the Defense
Threat Reduction Agency and the U.S. National Insti-
tutes of Health [4]. In addition, numerous state, non-
state and non-governmental organizations, such as the
Bill and Melinda Gates Foundation, the World Bank
and Médecins sans Frontières, contribute substantially
to capacity-building efforts around the world [5-7].
With the establishment of the Armed Forces Health
Surveillance Center (AFHSC) in late 2008, the DoD-
GEIS program was transitioned to a division and
renamed “AFHSC-GEIS”; however, its mission of work-
ing to promote and facilitate national and international
preparedness for EID was maintained. Strengthening of
U.S. military and host-country disease surveillance and
public health laboratory capacity represents a critical
step for contributing to compliance with the IHR (2005)
detection, reporting and response requirements. During
2009, capacity-building efforts were undertaken in a
variety of formats, including enhancement of diagnostic
capabilities, expansion of surveillance for militarily rele-
vant infectious and tropical diseases, and deployment of
electronic surveillance platforms. These efforts were
coordinated with local host-country health officials and
geographic Combatant Commands to ensure they
addressed country and regional medical priorities as
well as to ensure better surveillance and response to dis-
ease outbreaks and EID threats to U.S. forces abroad.
These efforts focused on influenza and other respiratory
diseases, malaria, dengue and other vector-borne ill-
nesses, acute diarrheal diseases, antimalarial and antimi-
crobial resistance, sexually transmitted diseases, and
bacterial wound infections.
Accomplishments
Laboratory infrastructure development
Capacity-building initiatives continued to represent a
major component of AFHSC-GEIS contributions to world-
wide EID surveillance and response activities. Inadequate
laboratory capacity in developing countries has been
termed the “Achilles’ heel” of global efforts to combat
infectious diseases [8]. Thus, many AFHSC-GEIS spon-
sored activities in capacity building were directed at
i m p r o v i n ge x i s t i n gi n f r a s t r u c t u r eb yr e n o v a t i n gc u r r e n t
laboratory facilities, furnishing new scientific equipment,
and provisioning new or enhanced diagnostic testing sys-
tems at overseas U.S. DoD facilities, as well as U.S.-based,
DoD influenza reference laboratories, which serve as regio-
nal reference laboratories, and host-country laboratories.
Efforts were coordinated with over 80 local and regio-
nal Ministries of Health, Agriculture and Defense, as
well as other government officials and institutions
worldwide in 74 countries. A total of 52 National Influ-
enza Centers (NICs) and other country-specific influ-
enza and EID reference laboratories (44 civilian, eight
military) were supported in 46 countries (Table 1). The
efforts included support to laboratories in eight regions
of the world. Sub-Saharan (east, central and west) Africa
were the regions with the most major laboratory capa-
city-building efforts (in 14 countries), consistent with
the identified needs of this region relative to the world,
especially as it relates to influenza [9,10]. Among all
infrastructure and capacity-building projects (Table 2),
the majority supported primarily human health entities
(in 67 countries); however, projects also supported ani-
mal health entities for zoonotic diseases in eight coun-
tries. Training efforts are mentioned, but are presented
in detail elsewhere in this supplement [11].
One of the most notable AFHSC-GEIS accomplishments
in fiscal 2009 was the establishment of two new biosafety
level-3 (BSL-3) laboratory suites within DoD reference
laboratories. The Armed Forces Research Institute of
Medical Sciences (AFRIMS) in Bangkok, Thailand, com-
pleted the first laboratory, which the United States certi-
fied and commissioned on July 8, 2009. The suite was
officially inaugurated September 16, 2009 and began
immediately supporting work in avian and pandemic influ-
enza monitoring, including culture and molecular sequen-
cing capability (Figure 1). This BSL-3 laboratory
constitutes the first DoD-certified laboratory of its kind in
the region and provides the World Health Organization
(WHO), Thailand and other countries in Southeast Asia
with a much-needed high-containment capability to con-
duct research and assist with outbreaks involving select
human and animal bacterial and viral strains.
The Naval Health Research Center (NHRC) opened a
second BSL-3 (agriculture-enhanced) laboratory suite in
late 2009. The facility allows work with zoonotic influ-
enza strains submitted by AFHSC-GEIS partners around
the world, including development of new virus neutrali-
zation testing capabilities against H5N1 and other highly
pathogenic avian influenza strains. Additionally, two
BSL-2 laboratories were also established at the Cameroon
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Global Viral Forecasting Initiative in Yaoundé and at the
University of Buea (Figure 2). Both facilities will greatly
improve the ability to conduct influenza and EID diag-
nostic work, as well as potentially advanced pathogen dis-
covery work in hard-to-reach locations in Africa.
Efforts were also undertaken to improve laboratory
capability for global influenza surveillance and diagnosis,
especially regarding the novel A/H1N1 influenza pan-
demic. To this end, AFRIMS established viral/bacterial
pathogen culture and molecular diagnostic capability in
their Nepal detachment to support the National Public
Table 1 2009 Major Laboratory Capacity-Building Initiatives by Geographic Region
Geographic Region Major Laboratory Capacity Building Initiative Countries Supported
Southeast Asia NIC & military influenza lab equipment, reagent & training support; EID
laboratory diagnostics & disease surveillance systems
Bhutan, Cambodia, Lao People’s Democratic
Republic, Nepal, Singapore, Thailand
Far East NIC & military influenza lab equipment & reagent support; EID lab
proficiency & equipment support
Japan, Korea, Philippines
East & Central Africa NIC & VHF lab equipment, reagent & training support; EID laboratory
diagnostics
Cameroon, Kenya, Tanzania, Uganda
West Africa NIC & MoH influenza lab equipment, reagent & training support; VHF lab
diagnostics & military EID lab diagnostic testing capacity
Benin, Burkina Faso, Cote d’Ivoire, Ghana,
Liberia, Mali, Niger, Nigeria, Sierra Leone, Togo
North Africa, Middle
East & Southwest Asia
NIC lab equipment, reagent & training support Afghanistan, Egypt, Iraq, Jordan, Kuwait, Oman,
Pakistan, Sudan, Syria
Central Asia EID & influenza lab equipment, reagent & training support Azerbaijan, Georgia, Mongolia
Europe Military & academic influenza lab equipment, reagent & training support Poland, Romania
Central & South
America
NIC & MoH influenza lab equipment, reagent & training support;
leishmania military reference lab equipment, reagent & training support
Colombia, Ecuador, El Salvador, Guatemala,
Honduras, Nicaragua, Panama, Paraguay, Peru
Acronyms: NIC, national influenza center; EID, emerging infectious diseases; VHF, viral hemorrhagic fever; MoH, Ministry of Health.
Table 2 2009 Capacity-Building Initiatives by Major Regional AFHSC-GEIS Supported Partners and Type
Partner
(see text)
Type of Infrastructure/Capacity Building* Centers/
Hospitals
Field
Sites
Countries*
AFRIMS Influenza & malaria/MDR labs (KH, PH); enteric & influenza lab upgrade (NP, TH); blood culture
(NP); influenza testing (BT); influenza antiviral resistance (TH)
22 51 5
NAMRU-2 Malaria, FVBI, enteric, blood culture & AMR testing (KH); influenza & AFI testing (ID, KH, SG);
surveillance data management (LA)
47 3 4
NAMRU-3 Influenza, blood culture & AMR testing (EG, JO); Influenza PCR/culture & antiviral resistance testing
(32 countries); Joint Biological Agent Identification & Detection System (5 deployed US military
sites-CENTCOM**); zoonotic disease & entomology (EG, DJ); AFI, blood/cerebrospinal spinal fluid
culture & serology testing (AZ, GE); Leishmania PCR & culture (EG, LR); rotavirus testing (6
countries); cholera & other ADD testing (7 countries); FVBI testing (EG, DJ, AZ, GE)
37 42 34
NMRCD-
Peru
Influenza PCR/culture & antiviral resistance testing support (10 countries); AFI & viral culture &
serology testing (PE, BO, EC, PY); Leishmania PCR, MDR, urine/vaginal PCR-STIs, Rickettsial PCR &
culture (PE); enteric culture, PCR & AMR testing (PE, EC, PY); Alerta electronic disease surveillance
system (PE, PA, EC)
23 102 11
USAMRU-
Kenya
Malaria/MDR, microscopy & PCR, rotavirus, cholera & other ADD testing, arboviral/VHF PCR &
culture, AFIs, blood culture & serology testing, STIs culture (KE); influenza PCR, culture &genotyping
(KE, UG, CM); influenza, AFI, FVBI, cholera & other ADDs (KE, TZ, NG)
76 9 5
PHCR-South Influenza PCR, culture & indirect immunofluorescence assay (US, HN, SV, NI, GT, PA); malaria,
Leishmania, & dengue PCR testing (HN)
47 6
Univ Iowa
CEID
Respiratory & other zoonotic respiratory EID testing & epidemiology (US, TH, KH, NG, RO, MN) 6 ~30 6
JHU/APL Influenza military treatment facilities (PIPM) modeling (US); SMS text & ESSENCE Desktop edition
system (PH); Open source Interactive Voice Recognition software surveillance (PE); OpenESSENCE
website software surveillance (US, PE); SMS text (PH)
1 ~125 3
Acronyms: MDR, multidrug resistance; FVBI, febrile & vector-borne illnesses; AMR, antimicrobial resistance; AFI, acute febrile illnesses (such as dengue,
leptospirosis and zoonotic infections); PCR, polymerase chain reaction; ADD, acute diarrheal diseases (such as traveler’s diarrhea, campylobacter, shigellosis,
salmonellosis); STIs, sexually transmitted infections, including Neisseria gonorrhea; EID, emerging infectious diseases; PIPM, Pandemic Influenza Prevention
Modeling; SMS, Short Message Service; ESSENCE, Electronic Syndromic Surveillance for Early Notification of Community-based Epidemics.
*Country names are displayed in parenthesis using the International Organization for Standardization (ISO 3166) two-character code (URL:
http://www.commondatahub.com/live/geography/country/iso_3166_country_codes?gclid=CPSnst2e5KQCFQqP5god3xzd8A); Countries column represents the
number where activities have been implemented; U.S. military deployment sites (such as Iraq, Afghanistan) or U.S. Department of State embassies do not
contribute to separate country counts, since they represent overseas locations where U.S. forces and/or civilians are deployed or stationed.
**CENTCOM, U.S. Central Command (forward U.S. troop deployment sites).
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Page 3 of 9Figure 1 AFRIMS BSL-3 Laboratory Commissioning. On September 16, 2009 (from left to right), Major General Krisada Duangurai, director
general of AFRIMS; U.S. Ambassador Eric John, together with Colonel James Boles, commander of AFRIMS, officiated the ribbon-cutting
ceremony for the AFRIMS BSL-3 laboratory. This facility significantly contributes to the country’s capacity to conduct research and investigate
outbreaks caused by agents, such as avian influenza, chikungunya virus and other endemic diseases throughout Southeast Asia.
Figure 2 Influenza Surveillance Capacity-Building Initiative with Global Viral Forecasting Initiative and University of Buea, Cameroon.
Two biosafety level-2 laboratories were renovated at the Cameroon Army Military Health Research Center in Yaoundé and at the University of
Buea, in cooperation with the Cameroon government and military. These laboratories have the capacity to isolate and characterize human and
animal influenza viruses, as well as other EID pathogens of unknown origin.
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transcriptase polymerase chain reaction (rRT-PCR) diag-
nostic capacity for influenza at a main tertiary-care hos-
pital of the Department of Health within the Visayas
region of the Philippines.
Developing influenza diagnostic capabilities at other
NICs was also supported by the U.S. Naval Medical
Research Unit No. 3 (NAMRU-3) in Afghanistan, Iraq
and Jordan; by the U.S. Naval Medical Research Center
Detachment in Peru (NMRCD-Peru) in the countries of
Colombia, Ecuador, Paraguay and Venezuela; and in
Kenya, by the U.S. Army Medical Research Unit-Kenya.
Finally, in conjunction with the CDC’s Central America
and Panama center, the U.S. Army Public Health Com-
mand Region-South (PHCR-South) provided laboratory
technical assistance, reagents and supplies to the Minis-
tries of Health (MoHs) in El Salvador, Guatemala, Hon-
duras, Nicaragua and Panama, resulting in the
certification of the Guatemalan NIC and the testing of
over 5,000 specimens for novel A/H1N1.
In collaboration with the Peruvian Navy, NMRCD-
Peru has built a robust shipboard disease surveillance
infrastructure with detection capability modeled very
closely on the NHRC shipboard surveillance system.
The early detection aspect of this system involves
equipping participating ships with real-time PCR diag-
nostic capability for emerging infectious diseases, such
as influenza or adenovirus. Short-term storage of sam-
ples allows for more in-depth, follow-up testing at the
laboratory in Lima or at other collaborating regional
laboratories. Since 2007, this system has successfully
identified and responded to numerous outbreaks of
respiratory, gastrointestinal and sexually transmitted
infections among active-duty Peruvian personnel
aboard ships [12]. More recently, this capability was
instrumental in identifying and responding to a large
outbreak of novel A/H1N1 on board a large deck ship
in the Pacific [13].
This investment in laboratory infrastructure develop-
ment has directly impacted the number of outbreak
investigations that the AFHSC-GEIS network has been
able to support. The capacity-building efforts contribu-
ted to outbreak responses in 76 instances in 53 coun-
tries, representing every major populated region of the
world, including support for the confirmation of the
first cases of novel A/H1N1 in 14 countries (United
States, Bhutan, Cambodia, Colombia, Djibouti, Ecuador,
Egypt, Kenya, Kuwait, Lao People’s Democratic Republic
(PDR), Lebanon, Nepal, Peru and the Republic of the
Seychelles) [12]. The laboratory infrastructure allows for
a c u t er e s p o n s ec a p a b i l i t ya n dt h ea b i l i t yt om o n i t o r
ongoing epidemics or shifting EID patterns, such as the
identification and continued monitoring of artemisinin-
resistant malaria in Southeast Asia by partners from
AFRIMS [14] and at the U.S. Naval Medical Research
Unit No. 2 (NAMRU-2) or the search for genetic muta-
tions within influenza viruses that may indicate resis-
tance to antiviral medications.
Training
It is important to recognize that capacity building not
only involves renovating laboratories and providing diag-
nostic equipment and supplies, but most important,
building human capacity. Through training public health
and laboratory personnel, the physical infrastructure
could be properly leveraged for optimal support of IHR
(2005) compliance. During 2009, AFHSC-GEIS sup-
ported 18 partner organizations that conducted 123
training initiatives in 40 countries involving at least
3,130 people, including many host-country personnel, in
direct support of assisting with compliance with IHR
(2005). Significant expansion of training activities was
attained in the areas of pandemic preparedness, out-
break investigation and response, EID surveillance, and
pathogen diagnostic techniques.
By engaging local health and other government offi-
cials and civilian institutions in training endeavors, the
U.S. military’s role as a key stakeholder in global public
health has improved; and many opportunities for EID-
related surveillance, research and capacity-building
initiatives have been leveraged to provide a platform for
public health training, described elsewhere in this sup-
plement [11].
Electronic surveillance initiatives
Electronic disease surveillance, another important com-
ponent of a comprehensive global public health disease
prevention and control strategy, contributes significantly
to capacity building and support for IHR (2005) compli-
ance in partner countries. Using electronic methods for
data collection and analysis has the potential to improve
the accuracy and timeliness of outbreak detection, as well
as to provide situational awareness during, or in the
aftermath of, an outbreak or pandemic. The AFHSC-
GEIS network has supported numerous initiatives in
electronic disease surveillance during the past several
years, in partnership with several DoD overseas labora-
tories, host-country Ministries of Health and Defense
and our technical partner, the Johns Hopkins University
Applied Physics Laboratory (JHU/APL).
AFHSC-GEIS has relied on the extensive experience
that JHU/APL acquired in the design and implementa-
tion of the Electronic Syndromic Surveillance for Early
Notification of Community-based Epidemics (ESSENCE)
system [15]. This electronic disease surveillance system,
used worldwide at all DoD military treatment facilities
(MTFs), the U.S. Veterans Health Administration system
and at least 12 states in the United States, served as a
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surveillance within the AFHSC-GEIS network. Tools
have been created to enable data collection from the
most sophisticated data sources to remote settings
where data have traditionally been difficult, if not
impossible, to collect. These tools have far-reaching
applicability in any resource-limited setting, whether
overseas or after a disaster in the United States. The fol-
lowing describes some of the efforts that have focused
on adapting electronic or syndromic surveillance techni-
ques to resource-limited settings.
Two electronic surveillance efforts were developed at
AFRIMS in Southeast Asia and optimized in 2009, includ-
ing a project with the Royal Thai Army (RTA) in remote
border areas, as well as a pilot short message service
(SMS)-based project in the Philippines, part of a joint
effort with JHU/APL and the Cebu City Health Office
(CHO). The Thai Unit-Based Surveillance (UBS) project
commenced in 2001 and originally covered areas along the
Thai-Cambodia border where the Thai MoH did not have
disease surveillance capabilities. The project, developed by
the RTA with support from AFRIMS and AFHSC-GEIS,
reports diseases in both military and local civilian popula-
tions by faxing reports or by voice via military radio. In
2009, the Thai-Myanmar border area was added and an
additional 497 personnel were trained. Version 2.0 of the
UBS simplified data collection from 216 symptoms and
categorization into 12 syndromes that are consistent with
the Thai MoH’s reporting requirements. This updated
system added questions about poultry exposure, leptos-
pirosis, novel A/H1N1 infection and chickungunya virus
infection. Although no major outbreaks of disease were
detected by this system in 2009, it continued to provide
situational awareness for the RTA and Thai MoH.
Dengue fever poses a significant health threat in the
Philippines. Current hospital-based surveillance is highly
valid, but poorly suited for rapid identification of dengue
”hot spots” because of delays associated with laboratory
confirmation. To capture this important data for the
purposes of surveillance, a more rapid, but less specific
surveillance method was implemented and compared to
the standard sentinel surveillance system. This pilot
study implements and evaluates a simple dengue surveil-
lance protocol using SMS text messages to send daily,
person-based dengue surveillance data from local Baran-
gay Health Centers (BHCs) to the city health office
(CHO) in Cebu City. The pilot activity was originally
established in five clinics as of March 2009, but was
soon instituted in all BHCs in the city. Beginning July 1,
2009, all BHCs have been identifying all patients report-
ing to clinic with fever. Each day, BHC personnel send
this information to the CHO, creating a text message
for each patient with fever. The SMS message contains
the date and clinic name, as well as the patient’s name,
age, gender and symptoms. The message is transferred
into a Microsoft Access© database, cleaned, and starting
July 2010, reviewed in the ESSENCE Desktop Edition
application to identify statistically significant increases in
reported fever cases.
Meanwhile, NAMRU-2 continued to support the opti-
mization of the Early Warning Outbreak Recognition
System (EWORS) at 11 reference and provincial hospi-
tals in the Lao PDR allowing local MoH officials to
monitor the impact and burden of tropical and infec-
tious diseases in the country in real time. The CDC cur-
rently funds most of the operating budget for EWORS
in Lao PDR. The system, jointly developed by the Indo-
nesian MoH and NAMRU-2 with AFHSC-GEIS funding,
is also being used in Indonesia as the national reporting
system. EWORS has additionally been used in Cambodia,
Peru and Vietnam, although it is no longer in use in
these countries because local health authorities favored
other surveillance systems.
In South America, NMRCD-Peru supported major
efforts in electronic disease surveillance, including conti-
nuation and optimization of Alerta, a public-private
initiative that has revolutionized surveillance for the Per-
uvian military during the past seven years. The Alerta
system has seen recent expansion to all branches of the
Peruvian military, as well as adoption by the MoH of one
other country in the region—Panama. This system identi-
fied 17 outbreaks during 2009, including influenza, den-
gue, mumps, malaria, hepatitis A and respiratory disease.
Finally, in collaboration with the JHU/APL group,
NMRCD-Peru worked to develop an electronic syndro-
mic surveillance system based on open-source software
for use in resource-limited environments. As a result, the
system can be sustained without continued major invest-
ments or software licensing fees. This effort involved the
development of interactive voice response reporting, as
well as building a web-based infrastructure and database
on an open-source version of the ESSENCE system
(OpenESSENCE) in use in the United States. Addition-
ally, NMRCD-Peru supported the systematic evaluation
of these electronic surveillance systems and research on
ways to improve reporting via electronic systems [16].
These electronic surveillance initiatives constitute a
vibrant portfolio that capitalizes on the expertise of the
JHU/APL group and numerous AFHSC-GEIS partners at
overseas laboratories and within host-country Ministries
of Health and Defense. Many of the lessons learned, chal-
lenges, successes and failures have been shared within
this network of collaborators, and a harmonized strategy
is emerging to develop and deploy an electronic disease
surveillance system that is modular and responsive to
various needs found in developing settings. This
approach should assist many countries in complying with
IHR (2005) by the 2012 deadline.
Sanchez et al. BMC Public Health 2011, 11(Suppl 2):S4
http://www.biomedcentral.com/1471-2458/11/S2/S4
Page 6 of 9Provision of technical expertise/reference
laboratory support
In addition to supporting laboratory infrastructure
development and new surveillance initiatives, AFHSC-
GEIS provided technical expertise in support of capa-
city-building efforts. In 2009, one of the largest such
efforts was the network’s global response to the novel
A/H1N1 influenza pandemic. For example, NAMRU-3
provided training on laboratory techniques for 73 scien-
tists and technical personnel from 32 countries in wes-
tern and northern Africa, the Middle East, and central
Asia, as well as equipment and reagent support to estab-
lished NICs in Egypt, Kuwait, Oman, Pakistan, Sudan
and Syria. Support for further viral characterization by
genetic sequencing and antiviral resistance testing was
also performed at NAMRU-3, with reference testing
support by the CDC in Atlanta. This virology diagnos-
tic-testing capacity building of national reference labora-
tories constituted an essential step in establishing the
capability for H5N1 and novel A/H1N1 detection and
rapid response, and resulted in a better understanding
of the epidemiologic patterns of respiratory viruses cir-
culating in the region. It also represented the first step
toward NIC accreditation and collaboration with the
WHO Global Influenza Surveillance Network in support
of influenza vaccine development. By linking countries
in regional and sub-regional networks and by fostering
participation in WHO missions to assess laboratory test-
ing capacity needs, NAMRU-3 played a direct role in
promoting IHR (2005) compliance.
Working closely with U.S. Central Command and U.S.
Africa Command, NAMRU-3 and the U.S. Navy Environ-
mental and Preventive Medicine Unit No. 2 (NEPMU-2)
provided focused laboratory assessment, training, emer-
gency supplies and quality assurance support to five mili-
tary, far-forward deployed, influenza testing laboratories in
Southwest Asia and assisted with the deployment of the
Joint Biological Agent Identification and Detection System
(JBAIDS) platform for confirmation of novel A/H1N1
cases in-theater. This capability subsequently proved criti-
cal when Expeditionary Medical Forces in Kuwait and
Djibouti were able to identify and respond to novel
A/H1N1 and seasonal influenza outbreaks, respectively.
Network expertise and competence were important in
supporting global influenza testing efforts. For instance,
the AFRIMS-supported laboratory in the Philippines
was designated by the Philippine NIC as the only other
facility authorized to conduct novel A/H1N1 testing, in
support of central and southern regions of the country
(specifically, Mindanao and Visayas).
Military-to-military (mil-mil) partnerships
Growing collaborative military-military partnerships and
surveillance exchanges among global network partners
and foreign military counterparts continued to be an
area of high interest and priority for AFHSC-GEIS. The
network currently supports active military partnerships
in 14 countries. These partnerships resulted in a num-
ber of collaborative response activities that supported
foreign military partners, multinational peacekeepers
and observers in joint exercises and missions.
T h el a t es p r i n ga n ds u m m e ro u t b r e a k so fn o v e l
A/H1N1 in military treatment facilities throughout
Europe resulted in collaboration between Landstuhl
Regional Medical Center and PHCR-Europe and the
German Military Reference Laboratory. The long-stand-
ing relationship between the U.S. European Command
and the German Army’s Public Health Service helped
assist in disseminating confirmed results through weekly
surveillance reports sent to military clinicians, hospital
commanders, and other public health officials within the
U.S. military and the local German public health infra-
structure. This arrangement greatly aided the U.S.
European Command’s ability to conduct surveillance for
novel A/H1N1 within the European military community
and assisted German government officials in monitoring
the level of disease within their country.
Efforts have been established to collaborate on more
expansive and cross-cutting surveillance systems with mili-
tary partners in Poland and Singapore. These efforts
include a wide spectrum of surveillance from electronic
early detection systems and routine laboratory-based senti-
nel surveillance to robust pathogen discovery initiatives
and focused public health research endeavors. Collabora-
tively, these efforts have developed significantly during the
past year and have helped serve as a model for other
AFHSC-GEIS partners to engage their regional foreign
military counterparts. These mil-mil partnerships with
allied countries allow for open collaboration, capacity
building and transparent dialogue between partner coun-
tries, and thus have the potential to develop a meaningful
framework to better understand disease dynamics among
military populations in different parts of the world. To
further foster opportunities for these mil-mil partnerships,
AFHSC-GEIS is working with the International Congress
on Military Medicine and the WHO by facilitating educa-
tional opportunities with regard to IHR (2005) and crea-
tion of a portfolio of robust epidemiological tools and
training that member countries can access as needed [17].
Future directions and challenges
Significant progress was attained in expansion of world-
wide EID surveillance and response initiatives in fiscal
2009 through the capacity-building efforts of the
AFHSC-GEIS network described above. At this juncture,
however, it is necessary to achieve realistic goals in terms
of maturation, standardization and unification of the divi-
sion’s global surveillance efforts. This can best be
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1) adopting objective metrics of evaluation, such as time-
liness of disease detection and reporting to higher levels,
proportion of sites submitting timely weekly or monthly
reports, proportion of investigated outbreaks with con-
firmed laboratory results, and proportion of confirmed
outbreaks with nationally recommended public health
response [18]; 2) ensuring future standardization of
genetic and molecular-based testing platforms (e.g., PCR-
based assays) across the network of partners; 3) establish-
ing electronic sequence data repositories for more effec-
tive information sharing with the CDC, WHO and local
regional health authorities (especially for influenza and
other respiratory pathogens); 4) continuing emphasis on
collaborative work with host-country partners to
empower them to reach IHR (2005) capacity-building
milestones by 2012; and, 5) achieving standardized
reporting schemes for all AFHSC-GEIS partners in the
areas of influenza, enteric diseases, febrile and vector-
borne illnesses, sexually transmitted infections, and anti-
microbial resistance monitoring. In this manner, the
AFHSC-GEIS network will continue to contribute to the
global efforts in disease control and prevention through
the DoD’s laboratory-based surveillance and by enhan-
cing harmonization of efforts with other key USG stake-
holders, such as the U.S. Department of Health and
Human Services, the U.S. Agency for International Devel-
opment and the U.S. Department of State.
Many challenges exist to building capacity for public
health in resource-limited settings, including achieving sus-
tainability of efforts after support is withdrawn, containing
the departure of highly-trained, capable scientists after
training, and minimizing the duplication of efforts among
multiple sponsor agencies within the USG and with other
organizations. Data sovereignty and data sharing are also
key issues that require transparency on the part of both the
sponsor and recipient in order to optimally conduct disease
surveillance that satisfies the spirit of IHR (2005). Solutions
to many of these challenges are sometimes difficult and fre-
quently require continuous re-evaluation of best of practice
solutions for individual settings.
Through the development of active, mutually suppor-
tive relationships with local health officials and the estab-
lishment of important protocol-driven clinical and
laboratory surveillance projects, AFHSC-GEIS supported
scientists have become relevant stakeholders within host-
country public health communities and are able to con-
tinue to work in the critical development of surveillance,
laboratory and communications infrastructure within
partner countries. In addition to the IHR (2005), the
AFHSC-GEIS global network recognizes the recently
released National Strategy for Countering Biological
Threats (PPD-2) as another guiding framework for align-
ment of our program with the larger USG initiatives [19],
keeping the maintenance of the U.S. military’sh e a l t h
(known as “Force Health Protection”) as our unique
niche in the setting of improving global public health.
Meaningful public health initiatives taking place in any
one of the partner countries within the AFHSC-GEIS
global network must aim for incremental, albeit sustain-
able, development of capacity on behalf of their partner
host countries and do so in line with the specific PPD-2
objectives and IHR (2005) competencies. In this manner,
small improvements in capacity, improved testing abil-
ities, and ultimately, compliance with reporting will lead
to benefits for the health of U.S. servicemembers and for
the health of the world.
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